{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:12:16Z","timestamp":1777529536357,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Key Project of Health and Family Planning Commission of Hubei Province, China","award":["WJ2017Z012"],"award-info":[{"award-number":["WJ2017Z012"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To determine the incidence of acute cardiac injury (ACI), the factors associated with ACI and the in-hospital mortality in patients with COVID-19, especially in severe patients. All consecutive in-patients with laboratory-confirmed COVID-19 from Tongji Hospital in Wuhan during February 1 and March 29, 2020 were included. The demographic, clinical characteristics, laboratory, radiological and treatment data were collected. Univariate and Firth logistic regression analyses were used to identify factors associated with ACI and in-hospital mortality, and Kaplan\u2013Meier method was used to estimate cumulative in-hospital mortality. Among 1031 patients included, 215 (20.7%) had ACI and 501 (48.6%) were severe cases. Overall, 165 patients died; all were from the severe group, and 131 (79.39%) had ACI. ACI (OR\u2009=\u20092.34, <jats:italic>P<\/jats:italic>\u2009=\u20090.009), male gender (OR\u2009=\u20092.58,<jats:italic> P<\/jats:italic>\u2009=\u20090.001), oximeter oxygen saturation (OR\u2009=\u20090.90, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), lactate dehydrogenase (OR\u2009=\u20093.26, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), interleukin-6 (IL-6) (OR\u2009=\u20098.59, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), high sensitivity C-reactive protein (hs-CRP) (OR\u2009=\u20093.29, <jats:italic>P<\/jats:italic>\u2009=\u20090.016), N-terminal pro brain natriuretic peptide (NT-proBNP) (OR\u2009=\u20092.94, <jats:italic>P<\/jats:italic>\u2009=\u20090.001) were independent risk factors for the in-hospital mortality in severe patients. The mortality was significantly increased among severe patients with elevated hs-CRP, IL-6, hs-cTnI, and\/or NT-proBNP. Moreover, the mortality was significantly higher in patients with elevation of both hs-cTnI and NT proBNP than in those with elevation of either of them. ACI develops in a substantial proportion of patients with COVID-19, and is associated with the disease severity and in-hospital mortality. A combination of hs-cTnI and NT-proBNP is valuable in predicting the mortality.<\/jats:p>","DOI":"10.1038\/s41598-020-77172-1","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T11:16:29Z","timestamp":1606216589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Factors associated with acute cardiac injury and their effects on mortality in patients with COVID-19"],"prefix":"10.1038","volume":"10","author":[{"given":"Xingwei","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongfu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangbo","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuxin","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hesong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"77172_CR1","doi-asserted-by":"publisher","first-page":"e480","DOI":"10.1016\/S2214-109X(20)30068-1","volume":"8","author":"Y Ji","year":"2020","unstructured":"Ji, Y., Ma, Z., Peppelenbosch, M. P. & Pan, Q. Potential association between COVID-19 mortality and health-care resource availability. Lancet Glob. Health 8, e480 (2020).","journal-title":"Lancet Glob. Health"},{"key":"77172_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England) 395, 497\u2013506 (2020).","journal-title":"Lancet (London, England)"},{"key":"77172_CR3","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jama.2020.4344","volume":"323","author":"E Livingston","year":"2020","unstructured":"Livingston, E. & Bucher, K. Coronavirus disease 2019 (COVID-19) in Italy. JAMA 323, 1335 (2020).","journal-title":"JAMA"},{"key":"77172_CR4","volume-title":"StatPearls","author":"M Cascella","year":"2020","unstructured":"Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C. & Di Napoli, R. StatPearls (StatPearls Publishing, Treasure Island, 2020)."},{"key":"77172_CR5","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England) 395, 1054\u20131062 (2020).","journal-title":"Lancet (London, England)"},{"key":"77172_CR6","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","volume":"5","author":"S Shi","year":"2020","unstructured":"Shi, S. et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 5, 802\u2013810 (2020).","journal-title":"JAMA Cardiol."},{"key":"77172_CR7","first-page":"E008","volume":"48","author":"C Chen","year":"2020","unstructured":"Chen, C. et al. Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi 48, E008 (2020).","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"77172_CR8","first-page":"456","volume":"48","author":"XW He","year":"2020","unstructured":"He, X. W., Lai, J. S., Cheng, J. & Zeng, H. Prognostic impact of cardiac injury in severe\/critically severe patients with COVID-19. Zhonghua Xin Xue Guan Bing Za Zhi 48, 456\u2013460 (2020).","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"77172_CR9","doi-asserted-by":"publisher","first-page":"105954","DOI":"10.1016\/j.ijantimicag.2020.105954","volume":"55","author":"C Zhang","year":"2020","unstructured":"Zhang, C., Wu, Z., Li, J.-W., Zhao, H. & Wang, G.-Q. The cytokine release syndrome (CRS) of severe COVID-19 and Interleukin-6 receptor (IL-6R) antagonist Tocilizumab may be the key to reduce the mortality. Int. J. Antimicrob. Agents 55, 105954 (2020).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"77172_CR10","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1084\/jem.169.6.2133","volume":"169","author":"KW Beagley","year":"1989","unstructured":"Beagley, K. W. et al. Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J. Exp. Med. 169, 2133\u20132148 (1989).","journal-title":"J. Exp. Med."},{"key":"77172_CR11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.4049\/jimmunol.1601574","volume":"199","author":"M L\u00f3pez-Monta\u00f1\u00e9s","year":"2017","unstructured":"L\u00f3pez-Monta\u00f1\u00e9s, M. et al. Antibody-dependent NK cell activation differentially targets EBV-infected cells in lytic cycle and bystander B lymphocytes bound to viral antigen-containing particles. J. Immunol. 199, 656\u2013665 (2017).","journal-title":"J. Immunol."},{"key":"77172_CR12","doi-asserted-by":"crossref","unstructured":"Q. Ye, B. Wang, J. Mao, The pathogenesis and treatment of the `Cytokine Storm' in COVID-19. J Infect, (2020).","DOI":"10.1016\/j.jinf.2020.03.037"},{"key":"77172_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","volume":"20","author":"X Cao","year":"2020","unstructured":"Cao, X. COVID-19: immunopathology and its implications for therapy. Nat. Rev. Immunol. 20, 269\u2013270 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"77172_CR14","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Qin","year":"2020","unstructured":"Qin, C. et al. Dysregulation of immune response in patients with COVID-19 in Wuhan, China. Clin. Infect. Dis. 71, 762\u2013768 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"77172_CR15","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S0140-6736(18)31923-8","volume":"392","author":"ASV Shah","year":"2018","unstructured":"Shah, A. S. V. et al. High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet (London, England) 392, 919\u2013928 (2018).","journal-title":"Lancet (London, England)"},{"key":"77172_CR16","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jacc.2017.05.062","volume":"70","author":"P Willeit","year":"2017","unstructured":"Willeit, P. et al. High-sensitivity cardiac troponin concentration and risk of first-ever cardiovascular outcomes in 154,052 participants. J. Am. Coll. Cardiol. 70, 558\u2013568 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"77172_CR17","doi-asserted-by":"publisher","first-page":"m1091","DOI":"10.1136\/bmj.m1091","volume":"368","author":"T Chen","year":"2020","unstructured":"Chen, T. et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 368, m1091 (2020).","journal-title":"BMJ"},{"key":"77172_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","volume":"109","author":"B Li","year":"2020","unstructured":"Li, B. et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin. Res. Cardiol. 109, 531\u2013538 (2020).","journal-title":"Clin. Res. Cardiol."},{"key":"77172_CR19","doi-asserted-by":"publisher","first-page":"104371","DOI":"10.1016\/j.jcv.2020.104371","volume":"127","author":"Y Hu","year":"2020","unstructured":"Hu, Y. et al. Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and meta-analysis. J. Clin. Virol. 127, 104371 (2020).","journal-title":"J. Clin. Virol."},{"key":"77172_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","volume":"5","author":"T Guo","year":"2020","unstructured":"Guo, T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 5, 811\u2013818 (2020).","journal-title":"JAMA Cardiol."},{"key":"77172_CR21","first-page":"E004","volume":"48","author":"YD Peng","year":"2020","unstructured":"Peng, Y. D. et al. Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV. Zhonghua Xin Xue Guan Bing Za Zhi 48, E004 (2020).","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"77172_CR22","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","volume":"17","author":"Y-Y Zheng","year":"2020","unstructured":"Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y. & Xie, X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol. 17, 259\u2013260 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"77172_CR23","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","volume":"116","author":"TJ Guzik","year":"2020","unstructured":"Guzik, T. J. et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc. Res. 116, 1666\u20131687 (2020).","journal-title":"Cardiovasc. Res."},{"key":"77172_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/CCM.0000000000004207","volume":"48","author":"C Gao","year":"2020","unstructured":"Gao, C. et al. Association between cardiac injury and mortality in hospitalized patients infected with avian influenza A (H7N9) virus. Crit. Care Med. 48, 451\u2013458 (2020).","journal-title":"Crit. Care Med."},{"key":"77172_CR25","unstructured":"National Health Commission of the People's Republic of China. Chinese management guideline for COVID-19 (version 6.0). https:\/\/www.nhc.gov.cn\/jkj\/s3577\/202003\/4856d5b0458141fa9f376853224d41d7\/files\/4132bf035bc242478a6eaf157eb0d979.pdf (2020)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77172-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77172-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77172-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T23:39:15Z","timestamp":1670369955000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77172-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["77172"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-77172-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"24 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20452"}}